INVO Fertility (NASDAQ:IVF) Announces Earnings Results

INVO Fertility (NASDAQ:IVF) posted its quarterly earnings data on Monday. The company reported ($0.77) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $1.76 million during the quarter.

INVO Fertility Stock Down 5.9%

NASDAQ:IVF opened at $0.43 on Wednesday. INVO Fertility has a 52 week low of $0.40 and a 52 week high of $37.44. The company has a market cap of $2.42 million, a PE ratio of -0.01 and a beta of 2.03. The business’s 50 day moving average is $0.72 and its two-hundred day moving average is $2.32.

Institutional Trading of INVO Fertility

A hedge fund recently bought a new stake in INVO Fertility stock. Citadel Advisors LLC purchased a new stake in INVO Fertility, Inc (NASDAQ:IVF) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned 1.19% of INVO Fertility as of its most recent filing with the SEC. 12.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of INVO Fertility in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, INVO Fertility has a consensus rating of “Sell”.

INVO Fertility Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.